BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 26943990)

  • 1. Post-Mastectomy Radiation Therapy for Invasive Lobular Carcinoma: A Comparative Utilization and Outcomes Study.
    Stecklein SR; Shen X; Mitchell MP
    Clin Breast Cancer; 2016 Aug; 16(4):319-26. PubMed ID: 26943990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period.
    Fortunato L; Mascaro A; Poccia I; Andrich R; Amini M; Costarelli L; Cortese G; Farina M; Vitelli C
    Ann Surg Oncol; 2012 Apr; 19(4):1107-14. PubMed ID: 21913022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast.
    Warneke J; Berger R; Johnson C; Stea D; Villar H
    Am J Surg; 1996 Nov; 172(5):496-500. PubMed ID: 8942552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Long-term Study of a Large Series of Patients with Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Loco-Regional Recurrence, Metastasis, and Survival.
    García-Fernández A; Lain JM; Chabrera C; García Font M; Fraile M; Barco I; Torras M; Reñe A; González S; González C; Piqueras M; Veloso E; Cirera L; Pessarrodona A; Giménez N
    Breast J; 2015; 21(5):533-7. PubMed ID: 26190560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma.
    Shah C; Wilkinson JB; Shaitelman S; Grills I; Wallace M; Mitchell C; Vicini F
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e547-51. PubMed ID: 21640491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
    Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
    Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes.
    Huo D; Hou N; Jaskowiak N; Winchester DJ; Winchester DP; Yao K
    Ann Surg Oncol; 2015 Dec; 22(13):4295-304. PubMed ID: 25820998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
    Zhao H
    Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Survival Differences Between T1-2 Invasive Lobular Breast Cancer and Corresponding Ductal Carcinoma After Breast-Conserving Surgery: A Propensity-Scored Matched Longitudinal Cohort Study.
    Wang K; Zhu GQ; Shi Y; Li ZY; Zhang X; Li HY
    Clin Breast Cancer; 2019 Feb; 19(1):e101-e115. PubMed ID: 30502219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmastectomy Radiation Therapy Is Associated With Improved Survival in Node-Positive Male Breast Cancer: A Population Analysis.
    Abrams MJ; Koffer PP; Wazer DE; Hepel JT
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):384-391. PubMed ID: 28463158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology.
    Moran MS; Yang Q; Haffty BG
    Breast J; 2009; 15(6):571-8. PubMed ID: 19995377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival following breast-conserving therapy is equal to that following mastectomy in young women with early-stage invasive lobular carcinoma.
    Yu TJ; Liu YY; Hu X; Di GH
    Eur J Surg Oncol; 2018 Nov; 44(11):1703-1707. PubMed ID: 30029824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.
    Bharat A; Gao F; Margenthaler JA
    Am J Surg; 2009 Oct; 198(4):516-9. PubMed ID: 19800459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes.
    Wasif N; Maggard MA; Ko CY; Giuliano AE
    Ann Surg Oncol; 2010 Jul; 17(7):1862-9. PubMed ID: 20162457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmastectomy radiation therapy for lymph node-negative, locally advanced breast cancer after modified radical mastectomy: analysis of the NCI Surveillance, Epidemiology, and End Results database.
    Yu JB; Wilson LD; Dasgupta T; Castrucci WA; Weidhaas JB
    Cancer; 2008 Jul; 113(1):38-47. PubMed ID: 18442108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin.
    Braunstein LZ; Brock JE; Chen YH; Truong L; Russo AL; Arvold ND; Harris JR
    Breast Cancer Res Treat; 2015 Jan; 149(2):555-64. PubMed ID: 25604797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
    Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
    Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical value of adjuvant radiotherapy in patients with early stage breast cancer with 1 to 3 positive lymph nodes after mastectomy.
    Wu SG; He ZY; Li FY; Wang JJ; Guo J; Lin Q; Guan XX
    Chin J Cancer; 2010 Jul; 29(7):668-76. PubMed ID: 20591219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with invasive lobular breast cancer are less likely to undergo breast-conserving surgery: a population based study in the Netherlands.
    Truin W; Roumen RM; Siesling S; van der Heiden-van der Loo M; Duijm LE; Tjan-Heijnen VC; Voogd AC
    Ann Surg Oncol; 2015 May; 22(5):1471-8. PubMed ID: 25323475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-excision rates of invasive ductal carcinoma with lobular features compared with invasive ductal carcinomas and invasive lobular carcinomas of the breast.
    Arps DP; Jorns JM; Zhao L; Bensenhaver J; Kleer CG; Pang JC
    Ann Surg Oncol; 2014 Dec; 21(13):4152-8. PubMed ID: 24980090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.